USPTO serial 79313379
MYRIO THERAPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 9, 2022
- Examiner
- HACK, ANDREA R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MYRIO THERAPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brendan J. Hughes
Brendan J. Hughes Cooley LLP1299 Pennsylvania Avenue, NW, Suite 700Washington, DC 20004UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Antibodies for scientific purposes, other than for medical or veterinary use; biological preparations for laboratory purposes; biological preparations for use in science and industry, namely, for use in the pharmaceutical industry; chemical preparations for use in science; chemical preparations for use in the pharmaceutical industry | ACTIVE | — |
| 005 | Therapeutic antibodies for the treatment of autoimmune diseases, oncological diseases, viruses; biological preparations for pharmaceutical purposes for the treatment of autoimmune diseases, oncological diseases, viruses; pharmaceutical preparations for treating autoimmune diseases, oncological diseases, viruses; pharmaceutical compositions for treating autoimmune diseases, oncological diseases, virus | ACTIVE | — |
| 042 | Scientific laboratory services for scientific research or analysis; laboratory research in the field of biology; scientific research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Myrio Therapeutics Pty Ltd
- Other trademarks owned by Myrio Therapeutics Pty Ltd
- Other trademarks owned by Myrio Therapeutics Pty Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MYRIO THERAPEUTICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 12, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 18, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 18, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 9, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 9, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 9, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 24, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 24, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 24, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 4, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 4, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 4, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 21, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 20, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 19, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 19, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 11, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 11, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 11, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 11, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 11, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Dec 13, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 23, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 23, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 26, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 25, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 26, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 22, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 17, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |